tiprankstipranks
InterCure (INCR)
NASDAQ:INCR
US Market
Holding INCR?
Track your performance easily

Intercure (INCR) Technical Analysis

88 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
InterCure’s (INCR) Moving Averages Convergence Divergence (MACD) indicator is 0.06, suggesting InterCure is a Sell.
InterCure’s (INCR) 20-Day exponential moving average is 1.62, while InterCure’s (INCR) share price is $1.7, making it a Buy.
InterCure’s (INCR) 50-Day exponential moving average is 1.59, while InterCure’s (INCR) share price is $1.7, making it a Buy.

Intercure (INCR) Pivot Points

Jan 22, 2025, 07:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.69
1.71
1.72
1.74
1.75
1.77
1.78
Fibonacci
1.71
1.72
1.73
1.74
1.75
1.76
1.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intercure (INCR) Moving Averages

Jan 22, 2025, 07:56 AM
Period
Simple
Exponential
MA5
1.69Buy
1.70Buy
MA10
1.67Buy
1.67Buy
MA20
1.63Buy
1.62Buy
MA50
1.49Buy
1.59Buy
MA100
1.69Buy
1.69Buy
MA200
2.10Sell
1.91Sell
InterCure’s (INCR) 10-Day exponential moving average is 1.67, while InterCure’s (INCR) share price is $1.7, making it a Buy.
InterCure’s (INCR) 100-Day exponential moving average is 1.69, while InterCure’s (INCR) share price is $1.7, making it a Buy.
InterCure’s (INCR) stock price is $1.7 and InterCure’s (INCR) 50-day simple moving average is 1.49, creating a Buy signal.
InterCure’s (INCR) stock price is $1.7 and InterCure’s (INCR) 100-day simple moving average is 1.69, creating a Buy signal.
InterCure’s (INCR) stock price is $1.7 and InterCure’s (INCR) 200-day simple moving average is 2.10, creating a Sell signal.

Intercure (INCR) Technical Indicators

Jan 22, 2025, 07:56 AM
Name
Value
Implied Action
RSI (14)
57.77
Neutral
STOCH (9,6)
65.50
Neutral
STOCHRSI (14)
71.24
Neutral
MACD (12,26)
0.06
Sell
ADX (14)
27.48
Neutral
Williams %R
-35.29
Buy
CCI (14)
76.93
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
40.99
Neutral
ROC
1.19
Buy
InterCure’s (INCR) Relative Strength Index (RSI) is 57.77, creating a Neutral signal.
InterCure’s (INCR) Trend Strength Indicator (ADX) is 27.48, creating a Neutral signal.
InterCure’s (INCR) Commodity Channel Index (CCI) is 76.93, creating a Neutral signal.
InterCure’s (INCR) Price Rate of Change (ROC) is 1.19, creating a Buy signal.

FAQ

Is INCR a Buy, Hold, or Sell?
Based on INCR’s technical indicators, INCR is a Buy.
    What is INCR’s RSI (14)?
    INCR’s RSI (14) is 57.77, which suggests INCR is a Neutral.
      What is INCR’s MACD?
      INCR’s MACD is 0.06, which suggests INCR is a Sell.
        What is INCR’s 5-day moving average?
        INCR’s 5-day moving average is 1.69, which suggests INCR is a Buy.
          What is INCR’s 20-day moving average?
          INCR 20-day moving average is 1.63, which suggests INCR is a Buy.
            What is INCR’s 50-day moving average?
            INCR’s 50-day moving average is 1.49, which suggests INCR is a Buy.
              What is INCR’s 200-day moving average?
              INCR’s 200-day moving average is 2.10, which suggests INCR is a Sell.
                What is INCR’s Williams % R (14)?
                INCR’s Williams % R (14) is -35.29, which suggests INCR is a Buy.
                  What is INCR’s CCI (14)?
                  INCR’s CCI (14) is 76.93, which suggests INCR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis